Avoro Capital Advisors’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Avoro Capital Advisors’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-388,990	Closed	-$4.08M	–	48
2016 Q1	$4.08M	Sell	388,990 -125,502	-24%	-$2.49M	1.42%	21
2015 Q4	$15.2M	Sell	514,492 -85,964	-14%	-$2.6M	5.23%	6
2015 Q3	$19M	Buy	600,456 +475,439	+380%	+$22.7M	4.93%	7
2015 Q2	$7.4M	Sell	125,017 -14,500	-10%	-$1.02M	2.04%	13
2015 Q1	$14.9M	Buy	139,517 +26,059	+23%	+$2.48M	5.72%	5
2014 Q4	$10.7M	Buy	+113,458	New	+$10.8M	7.22%	4

Other funds holding PTX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Avoro Capital Advisors's PTX Position: Q2 2016 in Review

Avoro Capital Advisors sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2016, closing a stake of 388,990 shares — an estimated $4.08M sold.

Avoro Capital Advisors first reported a position in PTX in Q4 2014 and held it in 6 quarters. The position peaked at $19M in Q3 2015. 56 funds tracked by Wall St. Rank hold PTX as of Q2 2016.

Avoro Capital Advisors reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2016 after selling out during the quarter.
Avoro Capital Advisors sold 388,990 Pernix Therapeutics Holdings, Inc. shares in Q2 2016, an estimated $4.08M.
Avoro Capital Advisors first reported a position in Pernix Therapeutics Holdings, Inc. in Q4 2014 and held it in 6 quarters.
Avoro Capital Advisors's Pernix Therapeutics Holdings, Inc. position peaked at $19M in Q3 2015.
56 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2016.

Based on Avoro Capital Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.